Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
07/2004
07/13/2004US6762321 Amide compounds and use thereof
07/13/2004US6762303 Method for producing pyridine compounds
07/13/2004US6762301 Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
07/13/2004US6762205 Phenyl sulfamate derivatives
07/13/2004US6762204 Taxol enhancer compounds
07/13/2004US6762198 Such as 2-((4'-methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl)-amino-3-(2-phenoxymethyl -(1,3)dioxan-2-yl)propionic acid
07/13/2004US6762196 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
07/13/2004US6762186 Use to treat allergy, nasal congestion, inflammatory and central nervous system-related diseases
07/13/2004US6762178 For use in treatment of disease conditions mediated by tnf-alpha, such as rheumatoid arthritis, osteoarthritis, sepsis, aids, ulcerative colitis, multiple sclerosis, crohn's disease, degenerative cartilage loss
07/13/2004US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation
07/13/2004US6762152 Four to seven membered heterocycles substituted on benzene ring; reaction of a ketone with a substituted benzoic acid
07/13/2004CA2358479C 4-substituted-2-(4-fluorophenylamino)-5,6 dimethylpyrimidine
07/08/2004WO2004056787A1 Cyclopentyl glutaramides and their use as neutral endopeptidase inhibitors
07/08/2004WO2004056778A1 Process for the synthesis of isonicotinic acid hydrazide
07/08/2004WO2004056777A1 Microsomal triglyceride transfer protein inhibitors
07/08/2004WO2004056776A1 Process for conversion of cyanopyridines to nicotinamides and catalyst therefor, process for preparing said catalyst
07/08/2004WO2004056775A1 Microsomal triglyceride transfer protein inhibitors
07/08/2004WO2004056774A2 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
07/08/2004WO2004056764A1 Aromatic derivatives as hiv aspartyl protease inhibitors
07/08/2004WO2004056762A2 Novel aminobenzophenone compounds
07/08/2004WO2004056750A1 Cyclopentil-substituted glutaramide compounds as endopeptidase inhibitors
07/08/2004WO2004056745A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
07/08/2004WO2004056744A1 Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
07/08/2004WO2004056740A1 Dicarboxylic acid derivatives as ppar-agonists
07/08/2004WO2004056735A1 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties
07/08/2004WO2004056727A2 Process of making chalcone derivatives
07/08/2004WO2004056365A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
07/08/2004WO2004056319A2 Substituted n-phenyl sulfonamide bradykinin antagonists
07/08/2004WO2004056178A2 Compounds useful as pesticides
07/08/2004WO2004046096A3 Novel ligands that are antagonists of raf receptors, process for preparing them and use thereof in human medicine and in cosmetics
07/08/2004WO2004037791B1 Inhibitors of glycogen synthase kinase 3
07/08/2004WO2004017920A3 Novel biphenyl and biphenyl-like cannabinoids
07/08/2004WO2004009017A3 Modulators of the glucocorticoid receptor and method
07/08/2004WO2003103599A3 Caspase-1 inhibitors and methods for their use
07/08/2004US20040133008 Amide compounds
07/08/2004US20040133005 Process for preparing substituted pyridnes
07/08/2004US20040133003 Process for preparing pyridinium fluorochromate (VI)
07/08/2004US20040132809 Cell adhesion inhibitors
07/08/2004US20040132804 1-aminoindane derivatives, e.g., 1-(cyclopentylcarbonylamino)-5-(4-cyclopropyl-2-(phenylsulfonyl)phenylsulfonyl)indane; exhibit anti-inflammatory and immunomodulatory activity
07/08/2004US20040132800 aminomethyl- or ethyl-substituted indoles, tetrahydrocarbazoles and tetrahydropyrido[1,2-a]indoles
07/08/2004US20040132786 Differential tumor cytotoxicity compounds and compositions
07/08/2004US20040132785 Thiolesters and uses thereof
07/08/2004US20040132782 Aspartyl protease inhibitors
07/08/2004US20040132780 Method and compositions for treating migraines
07/08/2004US20040132779 benzoyl- or pyridinoyl-amimo phenyl- or pyridinylmethylaminocarbonyl compounds, e.g., 4-[(2-acetylamino-2-phenyl-acetylamino)-methyl]-2-methylphenyl-4'-trifluoromethylbiphenyl-2-carboxamide; antiobesity and antiatherosclerosis agents
07/08/2004US20040132778 Method for treating retroviral infections
07/08/2004US20040132758 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders
07/08/2004US20040132745 carbamoyl-substituted aromatics, e.g., N-(butylcarbamoyl-phenyl-methyl)-6-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-nicotinamide; treating hypercholesterolemia, hypertriglyceridemia, pancreatitis, obesity and diabetic conditions
07/08/2004US20040132744 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications.
07/08/2004US20040132729 Inhibitors of p38
07/08/2004US20040132722 Glycoprotein-mediated MDR
07/08/2004US20040132718 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
07/08/2004DE10261272A1 Verfahren zur kontinuierlichen Herstellung von Zwischenprodukten für die Herstellung von 3-Hydroxypyridin-Verbindungen Process for the continuous preparation of intermediates for the preparation of 3-hydroxypyridine compounds
07/08/2004DE10261271A1 Verfahren zur Herstellung von Pyridoxin oder seines Säureadditionssalzes Process for the preparation of pyridoxine or its acid addition salt
07/08/2004CA2511360A1 Novel pharmaceuticals
07/08/2004CA2511202A1 Cyclopentil-substituted glutaramide compounds as endopeptidase inhibitors
07/08/2004CA2510815A1 Microsomal triglyceride transfer protein inhibitors
07/08/2004CA2510711A1 Novel aminobenzophenone compounds
07/08/2004CA2510471A1 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
07/08/2004CA2509881A1 Substituted n-phenyl sulfonamide bradykinin antagonists
07/08/2004CA2508621A1 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
07/08/2004CA2505604A1 Microsomal triglyceride transfer protein inhibitors
07/07/2004EP1435352A2 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
07/07/2004EP1434813A2 Polymers and oligomers, their synthesis, and electronic devices incorporating same
07/07/2004EP1434769A2 Compounds useful as reversible inhibitors of cysteine proteases
07/07/2004EP1434756A1 Novel compounds
07/07/2004EP1434624A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
07/07/2004EP1434585A1 Alkyne matrix metalloproteinase inhibitors
07/07/2004EP1434485A1 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides
07/07/2004EP1073431B1 Use of nmda antagonists for treatment of irritable bowel syndrome
07/07/2004EP0946232B2 Crystallisation process
07/07/2004CN1511150A Process for preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof
07/07/2004CN1511140A Oxime ether compound and agricultural or horticultural bactericide
07/07/2004CN1511137A Hydro phobic polyamine analogs and methods for their use
07/07/2004CN1156470C New Substituted pyridyl keto enols
07/07/2004CN1156452C Compound as anti-inflammatory agent
07/07/2004CN1156450C Process for preparing unsymmetric phenylpyridyl substances
07/07/2004CN1156449C Process for preparing N-(amino-4,6-dihalopyrimidine) formamide
07/06/2004US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/06/2004US6759544 Antimicrobially active acesulfame complexes, process for their preparation and their use
07/06/2004US6759428 Indole nitriles
07/06/2004US6759420 Low molecular weight, factor xa specific blood clotting inhibitors without side effects
07/06/2004US6759414 Aromatic amides
07/06/2004US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
07/06/2004US6759407 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, ESP as parasiticides
07/06/2004US6759101 Useful in ferroelectric liquid crystal compositions; use to lower melting point or lower freezing point, of liquid crystal compositions
07/06/2004CA2085201C New pyridyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
07/01/2004WO2004055015A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
07/01/2004WO2004054991A1 Ionic liquids comprising [n(cf3)2]- anions
07/01/2004WO2004054982A1 Biphenylcarboxamides
07/01/2004WO2004054977A1 Nicotinamide-based kinase inhibitors
07/01/2004WO2004054976A1 Process for preparing pyridinium fluorochromate (vi)
07/01/2004WO2004054579A1 2-pyridyl and 2-pyrimidyl cycloalkylene amide compounds as nr2b receptor antagonists
07/01/2004WO2004043928A3 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
07/01/2004WO2004031145A3 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
07/01/2004WO2004024878A3 Structurally rigid dopamine d3 receptor selective ligands and process for making them
07/01/2004WO2004022540A3 Pyridazinone and pyridone derivatives as adenosine antagonists
07/01/2004WO2004005513A3 Methods for specifically inhibiting histone deacetylase-7 and 8
07/01/2004WO2003090674A3 Compounds, compositions and methods for treating or preventing viral infections and associated diseases
07/01/2004WO2003045878A8 2,w-diaminocarboxylic acid compounds